Not all heroes wear lab coats in biomedical research, and some swing from trees. The cynomolgus monkey, other termed as the crab-eating macaque, is an indispensable partner and one of the animal models driving forward discoveries in immunology, infectious disease, and drug development for scientists tackling some of the toughest biomedical questions.
As evidenced by earlier and prevalent studies, e.g., MicroED and structural biology work leveraged cynomolgus monkey tissues to validate cross-species protein models, while research discussed by NPRC underscores their role in advancing therapies against HIV and metabolic disorders. Reports also reveal that the demand for a consistent non-human primate (NHP) resource supply is booming, yet the number of reliable providers still seem to be surprisingly scarce. For pharmaceutical companies under pressure to deliver breakthrough therapies faster, this scarcity has already become a bottleneck rather than a mere inconvenience.
Creative Biolabs Expands Access to Rare NHP Resources
Creative Biolabs immediately stepped in as they recognized the bottleneck brought by monkey resource scarcity and thus constructed a bank of monkey biological products, especially the Cynomolgus, to support researchers worldwide, accommodating high-quality bio-reagents from biofluids like whole blood to highly specific primary cell isolates, thereby granting easier access for labs to obtain critical materials without compromising on quality.
For instance, they supply cynomolgus monkey spleen endothelial cells of over 85% purity, which apply to a wide range of functional assay tests to facilitate vascular biology studies and provide insight into immune responses in real-world disease models. On their website, the cells are clearly specified:
- Source: Healthy cynomolgus monkey
- Purity: ≧ 85%
- Applications: Suitable for a wide range of safety assessments and functional assays.
- Organ/Tissue: Spleen
- Cell Type: Endothelial cells
- Cryopreservation: Cryopreserved with appropriate cryoprotectant.
- Quality Control: Rigorously control cell purity and viability.
- Cell Status: Cryopreserved
For cardiovascular research, which is estimated to reach USD 8.41 billion by 2030, the primary aortic fibroblasts and aortic smooth muscle cells provide pivotal research tools, as rodent models that often fail to replicate human-like responses can not play the role of substitution.
“Our customers who have integrated our materials into their projects have reported faster progress in drug validation pipelines and more reliable translational outcomes.” A scientist from the lab says.
In the fierce competition of drug discovery, shaving the time window of early stage development, even for a few weeks, means millions saved and lives impacted. Models like cynomolgus provide researchers an earlier, more realistic view of how therapeutics interact with human systems and predict outcomes. As defined as races against time in the biopharmaceutical industry, utilizing the right model means a lot by not only differentiating success and failure but also setting up the sense of research confidence with all going in the right direction. Creative Biolabs takes it as a commitment to pushing the biomedical frontier by means of supplying consistent monkey biosamples, more than just a business.
About
Creative Biolabs is a biotechnology company not only concentrating on today’s science, but also investing in tomorrow’s talents by setting up an annual scholarship program. For the 2025 turn, there is still time to apply before the deadline on Sept 30. The initiative has already attracted enthusiastic applications from students in biology, pharmacy, and biomolecular sciences, offering them financial support and visibility in the scientific community.
About the Author
Creative Biolabs supports laboratory NHP preclinical studies with a wide array of biological products, including whole blood, serum, plasma, primary cells, tissue, body fluids, and recombinant reagents. As a specialized contract research organization, we offer diverse NHP disease models, providing biologicals from diseased primates. Recognizing the complexity and sensitivity of NHPs in biomedical research, we have developed specialized infrastructure and care to maintain their well-being. Despite the controversy surrounding NHP use, we ensure a steady supply and high-quality service to meet the urgent needs of biomedical research through our dedicated monitoring and evaluation platform.
